Literature DB >> 12034052

Thyroid disease and lipids.

Leonidas H Duntas1.   

Abstract

The composition and the transport of lipoproteins are seriously disturbed in thyroid diseases. Overt hypothyroidism is characterized by hypercholesterolaemia and a marked increase in low-density lipoproteins (LDL) and apolipoprotein B (apo A) because of a decreased fractional clearance of LDL by a reduced number of LDL receptors in the liver. The high-density lipoprotein (HDL) levels are normal or even elevated in severe hypothyroidism because of decreased activity of cholesteryl-ester transfer protein (CETP) and hepatic lipase (HL), which are enzymes regulated by thyroid hormones. The low activity of CETP, and more specifically of HL, results in reduced transport of cholesteryl esters from HDL(2) to very low-density lipoproteins (VLDL) and intermediate low-density lipoprotein (IDL), and reduced transport of HDL(2) to HDL(3). Moreover, hypothyroidism increases the oxidation of plasma cholesterol mainly because of an altered pattern of binding and to the increased levels of cholesterol, which presents a substrate for the oxidative stress. Cardiac oxygen consumption is reduced in hypothyroidism. This reduction is associated with increased peripheral resistance and reduced contractility. Hypothyroidism is often accompanied by diastolic hypertension that, in conjunction with the dyslipidemia, may promote atherosclerosis. However, thyroxine therapy, in a thyrotropin (TSH)-suppressive dose, usually leads to a considerable improvement of the lipid profile. The changes in lipoproteins are correlated with changes in free thyroxine (FT(4)) levels. Hyperthyroidism exhibits an enhanced excretion of cholesterol and an increased turnover of LDL resulting in a decrease of total and LDL cholesterol, whereas HDL are decreased or not affected. The action of thyroid hormone on Lp(a) lipoprotein is still debated, because both decrease or no changes have been reported. The discrepancies are mostly because of genetic polymorphism of apo(a) and to the differences between the various study groups. Subclinical hypothyroidism (SH) is associated with lipid disorders that are characterized by normal or slightly elevated total cholesterol levels, increased LDL, and lower HDL. Moreover, SH has been associated with endothelium dysfunction, aortic atherosclerosis, and myocardial infarction. Lipid disorders exhibit great individual variability. Nevertheless, they might be a link, although it has not been proved, between SH and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034052     DOI: 10.1089/10507250252949405

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  169 in total

1.  Postprandial lipemia as a risk factor for cardiovascular disease in patients with hypothyroidism.

Authors:  Nedret Tanaci; Derun Taner Ertugrul; Mustafa Sahin; Muammer Yucel; Irem Olcay; Nilgun Guvener Demirag; Alptekin Gursoy
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

2.  Are hsCRP Levels and LDL/HDL Ratio Better and Early Markers to Unmask Onset of Dyslipidemia and Inflammation in Asymptomatic Subclinical Hypothyroidism?

Authors:  Mala Mahto; Baidarbhi Chakraborthy; Srinivas H Gowda; Harneet Kaur; Gaurav Vishnoi; Pramod Lali
Journal:  Indian J Clin Biochem       Date:  2012-04-18

Review 3.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

4.  Inappropriate heat dissipation ignites brown fat thermogenesis in mice with a mutant thyroid hormone receptor α1.

Authors:  Amy Warner; Awahan Rahman; Peter Solsjö; Kristina Gottschling; Benjamin Davis; Björn Vennström; Anders Arner; Jens Mittag
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-17       Impact factor: 11.205

5.  Thyroid Functional Disease and Mortality in a National Peritoneal Dialysis Cohort.

Authors:  Connie M Rhee; Vanessa A Ravel; Elani Streja; Rajnish Mehrotra; Steven Kim; Jiaxi Wang; Danh V Nguyen; Csaba P Kovesdy; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  J Clin Endocrinol Metab       Date:  2016-08-15       Impact factor: 5.958

6.  Thyroid stimulating hormone elevation as a predictor of long-term mortality in patients with acute myocardial infarction.

Authors:  Suk Min Seo; Yoon-Seok Koh; Hun-Jun Park; Dong Bin Kim; Sung Ho Her; Jong Min Lee; Chul Soo Park; Pum-Joon Kim; Hee Yeol Kim; Ki Dong Yoo; Doo Soo Jeon; Young Keun Ahn; Myung Ho Jeong; Wook Sung Chung; Ki-Bae Seung
Journal:  Clin Cardiol       Date:  2018-10-16       Impact factor: 2.882

7.  Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression.

Authors:  Ivan Tancevski; Andreas Wehinger; Egon Demetz; Philipp Eller; Kristina Duwensee; Julia Huber; Kathrin Hochegger; Wilfried Schgoer; Catherine Fievet; Frans Stellaard; Mats Rudling; Josef R Patsch; Andreas Ritsch
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

8.  Thyroid hormone status and health-related quality of life in the LifeLines Cohort Study.

Authors:  Elise I Klaver; Hannah C M van Loon; Riejanne Stienstra; Thera P Links; Joost C Keers; Ido P Kema; Anneke C Muller Kobold; Melanie M van der Klauw; Bruce H R Wolffenbuttel
Journal:  Thyroid       Date:  2013-09       Impact factor: 6.568

9.  Adrenocortical reserves in hyperthyroidism.

Authors:  Kemal Agbaht; Sevim Gullu
Journal:  Endocrine       Date:  2013-03-27       Impact factor: 3.633

Review 10.  Hypothyroidism as a risk factor for cardiovascular disease.

Authors:  Bernadette Biondi; Irwin Klein
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.